PRNCR1 and prostate carcinoma: The highly expressed cheRNAs PRNCR1 (also known as PCAT8) and PCGEM1 in prostate cancer can bind to the androgen receptor and mediate the cyclization of the promoters of androgen receptor binding enhancers and their target genes to promote the development of tumors (Yang et al., 2013).